Free Trial

RxSight (RXST) News Today

$47.83
-0.65 (-1.34%)
(As of 04:28 PM ET)
RXST Sep 2024 35.000 put
RxSight logo with Medical background
RxSight, Inc. (NASDAQ:RXST) Shares Purchased by Hillsdale Investment Management Inc.
Hillsdale Investment Management Inc. raised its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 50,653.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 76,130 shares of the company's stock a
RxSight logo with Medical background
Russell Investments Group Ltd. Reduces Stock Position in RxSight, Inc. (NASDAQ:RXST)
Russell Investments Group Ltd. reduced its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 26.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 167,577 shares of the company's stock
RxSight (NASDAQ:RXST) Trading 3.6% Higher
RxSight logo with Medical background
M&G Plc Buys New Stake in RxSight, Inc. (NASDAQ:RXST)
M&G Plc bought a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 141,428 shares of the company's stock, valued at approximately $7,354,000.
RxSight logo with Medical background
Inspire Investing LLC Acquires New Shares in RxSight, Inc. (NASDAQ:RXST)
Inspire Investing LLC bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 17,787 shares of the company's stock, valued at approximately $917,000. Other hedge funds and othe
RxSight logo with Medical background
RxSight (NASDAQ:RXST) Price Target Raised to $73.00
BTIG Research lifted their target price on RxSight from $72.00 to $73.00 and gave the stock a "buy" rating in a research report on Monday.
RxSight logo with Medical background
RxSight, Inc. (NASDAQ:RXST) Short Interest Update
RxSight, Inc. (NASDAQ:RXST - Get Free Report) was the target of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 1,850,000 shares, an increase of 22.5% from the June 15th total of 1,510,000 shares. Approximately 5.0% of the shares of the company are short sold. Based on an average trading volume of 435,600 shares, the short-interest ratio is presently 4.2 days.
RxSight: Great Business Model, Stretched Valuations
RxSight logo with Medical background
GSA Capital Partners LLP Buys New Holdings in RxSight, Inc. (NASDAQ:RXST)
GSA Capital Partners LLP bought a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 37,389 shares of the company's stock, valued at approximately $1,929,0
RxSight logo with Medical background
RxSight (NASDAQ:RXST) Price Target Cut to $70.00 by Analysts at Stifel Nicolaus
Stifel Nicolaus cut their price target on RxSight from $75.00 to $70.00 and set a "buy" rating on the stock in a research note on Wednesday.
RxSight logo with Medical background
Baillie Gifford & Co. Acquires Shares of 66,482 RxSight, Inc. (NASDAQ:RXST)
Baillie Gifford & Co. bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 66,482 shares of the company's stock, valued at approximately $3,429,000. Baillie
RxSight logo with Medical background
Capstone Investment Advisors LLC Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST)
Capstone Investment Advisors LLC raised its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 698.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 127,200 shares of the company's stock after acqu
RxSight logo with Medical background
RxSight, Inc. (NASDAQ:RXST) Stock Holdings Lifted by Principal Financial Group Inc.
Principal Financial Group Inc. raised its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 298.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 34,928 shares of the company's stock after buying an additional 26,164 shares d
RxSight logo with Medical background
RxSight (NASDAQ:RXST) Trading Down 1.8% After Insider Selling
RxSight (NASDAQ:RXST) Shares Down 1.8% After Insider Selling
RxSight logo with Medical background
Shelley B. Thunen Sells 10,000 Shares of RxSight, Inc. (NASDAQ:RXST) Stock
RxSight, Inc. (NASDAQ:RXST - Get Free Report) CFO Shelley B. Thunen sold 10,000 shares of the business's stock in a transaction on Monday, July 1st. The shares were sold at an average price of $58.61, for a total value of $586,100.00. Following the completion of the transaction, the chief financial officer now owns 13,938 shares of the company's stock, valued at $816,906.18. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
RxSight logo with Medical background
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Rating of "Buy" from Analysts
RxSight, Inc. (NASDAQ:RXST - Get Free Report) has received a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12 month price target among br
RxSight, Inc. (NASDAQ:RXST) Director Sells $906,250.00 in Stock
RxSight, Inc. (NASDAQ:RXST - Get Free Report) Director Julie Andrews sold 15,625 shares of the stock in a transaction on Friday, June 14th. The stock was sold at an average price of $58.00, for a total transaction of $906,250.00. Following the transaction, the director now owns 30,287 shares of the company's stock, valued at approximately $1,756,646. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Parkman Healthcare Partners LLC Has $20.69 Million Position in RxSight, Inc. (NASDAQ:RXST)
Parkman Healthcare Partners LLC boosted its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 34.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,032 shares of the company's stock after buyi
Lighthouse Investment Partners LLC Acquires New Stake in RxSight, Inc. (NASDAQ:RXST)
Lighthouse Investment Partners LLC acquired a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 22,433 shares of the company's stock, val
Seven Eight Capital LP Purchases New Position in RxSight, Inc. (NASDAQ:RXST)
Seven Eight Capital LP bought a new position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 26,918 shares of the company's stock, valued at approx
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Rating of "Buy" from Brokerages
RxSight, Inc. (NASDAQ:RXST - Get Free Report) has been given a consensus rating of "Buy" by the seven ratings firms that are covering the stock, Marketbeat reports. Seven equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts
15,931 Shares in RxSight, Inc. (NASDAQ:RXST) Purchased by Capstone Investment Advisors LLC
Capstone Investment Advisors LLC acquired a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 15,931 shares of the company's stock, valued at approximately $642,00
Trexquant Investment LP Sells 17,031 Shares of RxSight, Inc. (NASDAQ:RXST)
Trexquant Investment LP reduced its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 36.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 30,199 shares of the company's stock after selling 17,031 shares during the quarter. Trexquant Investme
Artisan Partners Limited Partnership Reduces Holdings in RxSight, Inc. (NASDAQ:RXST)
Artisan Partners Limited Partnership decreased its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,395,672 shares of the company's stock after selling 42,093 shares during the p
204,015 Shares in RxSight, Inc. (NASDAQ:RXST) Acquired by Great Lakes Advisors LLC
Great Lakes Advisors LLC bought a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 204,015 shares of the company's stock, valued at approximate
RxSight (NASDAQ:RXST) Stock Price Down 3.1%
RxSight (NASDAQ:RXST) Shares Down 3.1%
Nicholas Investment Partners LP Buys New Position in RxSight, Inc. (NASDAQ:RXST)
Nicholas Investment Partners LP acquired a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 56,414 shares of the company's stock, valued at appro
Victory Capital Management Inc. Has $10.35 Million Holdings in RxSight, Inc. (NASDAQ:RXST)
Victory Capital Management Inc. raised its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 108.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 256,684 shares of the company's stock after buying an additional 1
RxSight (NASDAQ:RXST) Shares Gap Down to $60.66
RxSight (NASDAQ:RXST) Shares Gap Down to $60.66
What 10 Analyst Ratings Have To Say About RxSight
RxSight (NASDAQ:RXST) Price Target Raised to $68.00 at Wells Fargo & Company
Wells Fargo & Company increased their price target on RxSight from $61.00 to $68.00 and gave the company an "overweight" rating in a research report on Tuesday.
RxSight (NASDAQ:RXST) Shares Gap Up on Analyst Upgrade
RxSight (NASDAQ:RXST) Shares Gap Up on Analyst Upgrade
RxSight (NASDAQ:RXST) Posts Earnings Results
RxSight (NASDAQ:RXST - Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by ($0.08). The company had revenue of $29.51 million during the quarter, compared to analyst estimates of $27.56 million. RxSight had a negative net margin of 54.57% and a negative return on equity of 31.16%. The firm's revenue for the quarter was up 68.7% compared to the same quarter last year. During the same quarter last year, the business earned ($0.42) EPS.
Get RxSight News Delivered to You Automatically

Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter.

Former Hedge Fund Manager Issues Crash Prediction (Ad)

Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.

Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now.

RXST Media Mentions By Week

RXST Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RXST
News Sentiment

1.00

0.47

Average
Medical
News Sentiment

RXST News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RXST Articles
This Week

6

3

RXST Articles
Average Week

Get RxSight News Delivered to You Automatically

Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RXST) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners